Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye
- PMID: 438963
- DOI: 10.1002/jps.2600680411
Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye
Abstract
The temporal and spatial pattern of [3H]-pilocarpine nitrate distribution in the albino rabbit eye following topical administration was determined. A four-compartment caternary chain model describing this disposition corresponds to the precorneal area, the cornea, the aqueous humor, and the lens and vitreous. Simultaneous computer fitting of data from tissue corresponding to some compartments in the model supported the proposed model. Additional support was provided by the excellent correlation between predicted and observed values in multiple-dosing studies. Several important aspects of ocular drug disposition are evident from the model. The extensive parallel elimination at the absorption site gives rise to an apparent absorption rate constant that is one to two orders of magnitude larger than the true absorption rate constant. In addition, aqueous flow accounts for most of the drug removal. Thus, major effects on absorption and elimination, independent of the drug structure, suggest the possibility of similar pharmacokinetics for vastly different drugs.
Similar articles
-
A comprehensive insight on ocular pharmacokinetics.Drug Deliv Transl Res. 2016 Dec;6(6):735-754. doi: 10.1007/s13346-016-0339-2. Drug Deliv Transl Res. 2016. PMID: 27798766 Free PMC article. Review.
-
Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.J Pharm Sci. 1979 Jun;68(6):673-84. doi: 10.1002/jps.2600680606. J Pharm Sci. 1979. PMID: 458563
-
Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.J Pharm Sci. 1976 Sep;65(9):1295-301. doi: 10.1002/jps.2600650909. J Pharm Sci. 1976. PMID: 966141
-
Age-related differences in ophthalmic drug disposition I. Effect of size on the intraocular tissue distribution of pilocarpine in albino rabbits.Biopharm Drug Dispos. 1981 Jul-Sep;2(3):215-33. doi: 10.1002/bdd.2510020303. Biopharm Drug Dispos. 1981. PMID: 7295879
-
Clinical pharmacokinetics of the eye. Proctor lecture.Invest Ophthalmol Vis Sci. 1981 Oct;21(4):504-41. Invest Ophthalmol Vis Sci. 1981. PMID: 6116682 Review.
Cited by
-
Modeling of corneal and retinal pharmacokinetics after periocular drug administration.Invest Ophthalmol Vis Sci. 2008 Jan;49(1):320-32. doi: 10.1167/iovs.07-0593. Invest Ophthalmol Vis Sci. 2008. PMID: 18172109 Free PMC article.
-
A comprehensive insight on ocular pharmacokinetics.Drug Deliv Transl Res. 2016 Dec;6(6):735-754. doi: 10.1007/s13346-016-0339-2. Drug Deliv Transl Res. 2016. PMID: 27798766 Free PMC article. Review.
-
General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.Pharm Res. 2016 Nov;33(11):2680-90. doi: 10.1007/s11095-016-1993-2. Epub 2016 Jul 18. Pharm Res. 2016. PMID: 27431864
-
Partitioning and Spatial Distribution of Drugs in Ocular Surface Tissues.Pharmaceutics. 2021 May 4;13(5):658. doi: 10.3390/pharmaceutics13050658. Pharmaceutics. 2021. PMID: 34064499 Free PMC article.
-
Human corneal cell culture models for drug toxicity studies.Drug Deliv Transl Res. 2016 Dec;6(6):660-675. doi: 10.1007/s13346-016-0330-y. Drug Deliv Transl Res. 2016. PMID: 27613190 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources